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Requirement for Specific Proteases in Cancer Cell
Intravasation as Revealed by a Novel
Semiquantitative PCR-Based Assay
ªspontaneousº metastasis is not understood. Most
transplantable human tumors are capable both of pro-
ducing ªprimaryº growth and, when injected directly into
arterial or venal circulation, a route that bypasses the
need for intravasation, of producing ªexperimental me-
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tastasesº in xenogeneic hosts, such as nude or SCID
mice or chick embryos. (Establishment of such metasta-Summary
ses usually requires direct intravascular delivery of a
relatively large number of cancer cells.) Thus, mostProteases are crucial for cancer metastasis, but due
transplantable tumors may have lost the properties re-to lack of assays, their role in intravasation has not
quired for invading blood vessel walls, a defect thatyet been tested. We have developed a human Alu se-
would severely diminish the number of cancer cells de-quence PCR-based assay to quantitate intravasated
livered into the circulation and reduce the chances ofcells in an in vivo model. We demonstrated that metal-
metastatic growth. Those that metastasize spontane-loproteinases (MMPs), and most likely MMP-9, are re-
ously in experimental models should be able to intrava-quired for intravasation by showing that marimastat,
sate efficiently.an inhibitor of MMPs, reduced intravasation by more
To identify properties that define cells capable of suc-than 90%, and that only tumor cell lines expressing
cessful intravasation, it was imperative to develop aMMP-9 intravasated. Cells with low surface urokinase
quantitative in vivo assay in which intravasation couldplasminogen activator (uPA) and uPA receptor (uPAR)
be measured. We used a human squamous cell carci-were also incapable of intravasation, despite the pres-
noma of head and neck (HEp3), which we showed to beence of high levels of MMP-9. We concluded that
highly metastatic when inoculated onthe chorioallantoicbreaching of the vascular wall is a rate-limiting step
membrane (CAM) of an artificially created air sac inchickfor intravasation, and consequently for metastasis,
embryo (Ossowski and Reich, 1980, 1983a). We tookand that cooperation between uPA/uPAR and MMP-9
advantage of the fact that during the creation of the airis required to complete this step.
sac, a requisite for preparation of the CAM for inocula-
tion, the CAM epithelium and basement membrane areIntroduction
damaged. As a result, even noninvasive cellsare allowed
almost unobstructed entry into the loose, highly vascu-The spread of cancer cells from a primary tumor to a site
larized connective tissue (Ossowski, 1988a). Initial ex-of metastasis formation involves multiple interactions,
periments aiming at recovering and quantitating circu-such as invasion of extracellular matrix, neovasculariza-
lating intravasated cells in blood samples proved to betion, invasion of theblood vessel wall (intravasation), exit
unsuccessful. Cancer cells could not be detected evenfrom the circulation, and establishment of secondary
in blood samples taken within minutes after intravenous
growth. Because cancer cells reach distant sites by
inoculation of 0.5±1.0 3 105 cells because they adhere
disseminating through blood or lymphatic circulation,
very rapidly to the endothelium (H. Russo-Payne and
breaching of the vasculature wall is a crucial event in
L. O., unpublished results).
metastasis formation. It is not known how early in the
An approach that proved to be successful involved
disease progression cancer cells acquire the ability to
inoculation of cancer cells on the wounded CAM of the
intravasate. However, once established, this pathway
artificial air sac created on the upper, larger circumfer-
appears to remain active, as cancer cells can be de- ence of the egg (see Figure 1). Since, as mentioned,
tected in repeated blood samples of cancer patients.
this method allows unobstructed access to the CAM
While most aspects of cancer dissemination have been
connective tissue, we reasoned that the profusion of
extensively studied, very little biochemical information
capillaries in the CAM would ensure that many inocu-
related to the process of intravasation is available. This lated cells would find themselves in proximity to a ves-
may be in part due to the paucity of experimental models sel, and those capable of invading the vessel wall would,
capable of mimicking the cellular and molecular interac- after alternating between floating and attached state,
tions required for a successful completion of intravasa- arrest in capillaries or postcapillary venules of various
tion. Existing models, such as mouse bladder (Poste et organs, including theªlowerº CAM (see scheme inFigure
al., 1980) or human amnion, denuded of epithelium and 1). To detect and quantitate these cells, we utilized PCR
reseeded with endothelial cells (Foltz et al., 1982), are amplification of human specific Alu sequences, which
used infrequently because they recapitulate poorly the represent z5% of human genomic DNA. We targeted
structure of blood vessels and, in particular, small ves- the ªlower CAMº for analysis because, as the respiratory
sels such as capillaries and postcapillary venules, where organ of the embryo, the CAM has a dense network of
most of thecancer cell invasion is believed to take place. blood capillaries, increasing the potential for entrap-
The scarcity of ªspontaneouslyº metastasizing human ment of a larger number of cancer cells.
tumors in experimental animals is another obstacle to Using this method, we were able to establish the kinet-
the study of intravasation. The reason for the inefficient ics of intravasation and to determine crucial cellular
properties required for successful completion of this
process.*To whom correspondence should be addressed.
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mix. (Only the 220 bp band was used for quantitation.)
If predetermined experimental conditions (number of
PCR cycles and the amount of radioactive nucleotide
added) are kept constant, the standard curve (Figure
2B) can be used to extrapolate the numbers of human
tumor cells present in unknown samples.
In the first in vivo experiment the dose-dependence
of intravasation was tested by inoculating CAMs with
increasing (0.5±2.0 3 106) numbers of cells and quanti-
tating the cells arrested in the vasculature of the lower
CAM (Figure 1), a compartment physically connected to
the site of inoculation only through blood and lymphatic
vessels. As shown in Figures 2C and 2D, one of the two
embryos inoculated with the lowest (0.5 3 106) number
of cells had z50 intravasated cells, and the other one
was negative. (In three additional experiments, only two
out of six embryos inoculated with 0.5 3 106 HEp3 cells
had z50 cells [limit of detection] in lower CAMs; the
rest were negative, results not shown.) Lower CAMs of
embryos inoculated with either 1 or 2 3 106 HEp3 cells
were always positive, and the number of cells was pro-
portional to the inoculum.
Figure 1. Scheme of the Intravasation Assay To determine the time dependence of intravasation,
Tumor cell suspensions, or fragments, are inoculated on CAMs of CAMs were inoculated with 1 3 106 HEp3 cells, and
artificially generated air sacs. In the process of air sac generation, DNA was extracted from lower CAMs at 5 min and 6,
the ªupper CAMº is wounded and parts of the chorionic epithelium 16, 24, 32, and 54 hr. No cancer cells were found in the
and basement membrane are damaged, exposing loose, vascu-
lower CAMs harvested at 5 min to 24 hr postinoculation,larized stroma. Tumor cells can enter this tissue regardless of their
indicating that either no intravasation had taken placeinvasive potential (Ossowski, 1988a), but only cells capable of pene-
or that the number of cells arrested during the 24 hr wastrating the blood vessel walls subsequently circulate and arrest in
vessels of embryonic and extraembryonic tissues. To quantitate ,50 or ,0.005% of the inoculum (Figure 2E). These
tumor cells entrapped in the ventral ªlower CAM,º the egg is cut results also indicated that this assay, rather then mea-
along the long circumference, and the upper half (with the inoculum) suring passive entry of cancer cells into injured blood
is discarded. The content of the lower half of the egg is also dis- vessels, measures an active process of intravasation.
carded, the CAM that lines the cavity of the eggshell is lifted and
The number of intravasated cells found 54 hrafter inocu-snap-frozen, and genomic DNA is extracted and used as a template
lation was, as determined from the reconstruction curvefor human Alu sequence amplification by PCR.
(Figure 2B), 4- to 5-fold greater than after 32 hr. This
increase was mostly due to continuous seeding of can-
Results cer cells from the primary site and, to a much lesser
degree, due to cell division. That intravasation is an
PCR Amplification of Human Alu active process is further supported by the observation
SequencesÐSensitivity and that not only dissociated single cells, but fragments of
Specificity of the Method HEp3 tumors containing a similar number of cancer cells
Prior to quantitating human cancer cells in vivo, a stan- display a comparable degree of intravasation (Figure
dard curve was constructed by mixing DNA of uninocu- 2F) that appears to proceed with similar kinetics (results
lated CAMs with DNA of increasing numbers of cancer not shown). This observation opens the possibility for
cells and using aliquots of 1 mg of the DNAs as templates direct testing of surgical cancer specimens for their abil-
in a PCR amplification of human Alu sequences. Be- ity to intravasate.
cause the reaction mixture contained 32P-labeled dCTP In addition, we showed that mixtures of mouse and
following separation of the PCR products on PAGE, the human genomic DNA could also be analyzed in a similar
resultant bands could be autoradiographed and quanti- way and, although the background was slightly greater
tated by scanning densitometry. When the mix contained than with chick tissue, it was possible to produce spe-
between 50 and 800 cancer cellsper CAM, a strong band cific, easily recognizable bands that could be densito-
of the expected size of 220 bp was amplified (Figure 2A); metrically scanned (Figure 3), expanding the potential
with .800 cancer cells in the mix, larger fragments of use of this method to nude or SCID mice.
variable sizes were amplified. Fifty cells per CAM (Figure
2A) is equivalent to one human cell in 2 3 106 host
cells, a level of sensitivity achieved because of the high Intravasation by Cancer Cells of Dissimilar
Malignant Potentialcontent of Alu sequences present in human genomic
DNA (Kariya et al., 1987).Figure 2B, inwhich densitomet- Pairs of cancer cell lines of high and low malignant po-
tential originating from breast (MDAMB231 and MCF-7)ric units were plotted as a function of known numbers
of cancer cells, shows that within almost 1.5 log range and prostate (PC3 and LNCaP) carcinomas, and a fibro-
sarcoma (HT1080) and primary human embryo fibroblaststhere is a direct relationship between the intensity of
the bands and the number of cancer cells present in the (HEF) pair were compared for their ability to intravasate;
Proteases in Cancer Intravasation and Alu-PCR
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Figure 2. PCR Amplification of Alu Sequences in a Mixture of Human and Chicken CAM DNA
(A) Reconstruction curve. Genomic DNA of lower CAMs was mixed with DNA equivalent of 0±6400 HEp3 cells. One-microgram aliquots (in
duplicate) of the DNAs were used to amplify human Alu sequences in the presence of 32P-dCTP and were analyzedby PAGE and autoradiography
as described in Experimental Procedures. The intensity of the z220 bp band increased with increased content of human cancer cells.
(B) Ratio between band intensity and human cell content. Bands produced by PCR amplification in (A) were scanned by densitometer and
the values plotted as a function of human cell number equivalent added to the CAMs. The plot shows a linear relation for over an z20-fold
range. When .1000 human cancer cells are present per lower CAM, their number is underestimated by this assay.
(C) Dose dependence of intravasation measured by Alu-PCR. HEp3 cells isolated from tumors and grown in culture were detached with EDTA,
resuspended in PBS at 0.5, 1.0, and 2.0 3 106 cells per 50 ml, and inoculated on CAMs. Fifty hours after inoculation, the lower CAMs were
excised, and human Alu sequences were amplified.
(D) Bands shown in (C) were scanned, and the numbers of cancer cells were calculated by extrapolation from the plot shown in (B). (The bars
are ranges of the two values.) Note the linear ratio between the number of cells in the inoculum and the number of intravasated cells.
(E) Time dependence of intravasation. HEp3 cells (1 3 106/CAM) were prepared and inoculated as in (C), except that DNA was extracted from
the lower CAMs at the indicated times. No cells were detected in lower CAMs before 32 hr postinoculation, indicating that intravasation is
an active process.
(F) Intravasation of tumor fragments. Single cell suspensions of HEp3 cells (1 3 106/CAM, designated Cells) and tumor fragments (several z2
mm2 fragments of a HEp3 CAM tumor, calculated to contain a total of z1 3 106 tumor cells) were inoculated on CAMs, and the DNAs of the
lower CAMs were extracted and analyzed as in (C).
malignant HEp3 cells served as a positive control. Figure Is Failure to Detect Intravasated Cancer Cells
Linked Directly to Their Inability to Invade4A, which is a composite of three individual experiments
in which intravasation by MDAMB231, HT1080, and PC3 Blood Vessel Walls or to Other Factors?
In addition to a defect in the ability to invade bloodcells was compared to that of HEp3 cells, shows that
these three cell lines, chosen for their recognized malig- vessel walls, other factors may potentially influence the
level of intravascular cancer cells. For example, a defectnant potential in immunosuppressed mice, intravasate
as efficiently as HEp3 cells. In contrast, MCF-7, HEF, in adhesion to endothelium would cause recirculation
and increase death of cancer cells due to shearingand LNCaP cells appear incapable of intravasation. The
inability of MCF-7 and HEF cells to intravasate was not stress. Also, an inoculum of cells with reduced prolifera-
tive capacity would provide a relatively smaller pool ofremedied by extending the assay to up to 5 days (Figure
4B), which dramatically increased the number of intrava- cells capable of intravasation. To equalize the access of
cell into the intravascular compartment, cellsof differentsated HEp3 cells.
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Figure 5. Arrest of Cells in Lower CAMs after Intravenous Injection
Cells (2 3 105 or less) were resuspended in 50 ml PBS and injected
into a blood vessel of the upper CAM of 10.5-day-old embryos. The
lower CAMs were collected (see Figure 1) 4 hr after injection and
processed as described in Experimental Procedures.
Figure 3. PCR Amplification of DNA of Human Tumor Cells Mixed 4A and 4B. This conclusion was confirmed by showing
with Mouse Tissues
that under conditions mimicking the shearing stress ex-
DNA extracted from nude mouse liver or lung was mixed with DNA
erted on tumor cells in the circulation, HEp3 cells withextracted from HEp3 cells ata ratio of tumor to mouse cells indicated
vastly different ability to intravasate (see below) werein the figure. Aliquots of 1 mg of genomic DNA were used as template
equally capable to adhere to chick and human endothe-for PCR amplification. Note that although mouse DNA produces
some background amplification, it is possible to discern and scan lium (Figure 6). That this interaction was similar for both
the specific 220 bp human Alu bands. chicken and human endothelium suggests that, at least
at this level, the chick embryo is a good model for testing
human tumor cells.
origin were delivered by intravenous injection. (Thenum-
To exclude the possibility that the high intravasation
ber of cells injected was 2 3 105 or less, since larger
capacity of some cell lines is due to their high prolifera-
inocula of some of the cell types were previously found
tion rate in vivo, we tested their growth by inoculating
to be lethal; results not shown.) Each of the cell types
0.5 3 106 cells per CAM and incubating the inoculated
tested, including normal human fibroblasts, was de-
embryos for a week. For cells that did not produce tu-
tected in the lower CAM 4 hr (Figure 5) and 24 hr (results
mors in this time period, the inoculum was increased to
not shown) after intravenous injection. Thus, it appears
2 3 106 cells per CAM. Table 1 shows that only HEp3
that differences in adherence to endothelium and/or cell
and HT1080 grew progressively on CAMs forming large
capillary trapping cannot explain the differences in the
(z400 mg) tumors. Neither breast nor prostate cancer
level of cell detected in the lower CAM shown in Figures
cell lines, including MDAMB231 and PC3, which intrava-
sated as efficiently as HEp3, produced tumors on CAMs.
(Small nodules were evident at the site of inoculation of
all cells, but they did not increase in size even after two
additional in vivo passages.) Thus, in the short (50 hr)
time period required to complete the intravasation
assay, proliferation rate had a negligible effect on the
number of cells found in the lower CAM. These results
Figure 4. Intravasation of Cells with Unequal Malignant Potential
(A) Human cell lines capable of producing invasive and/or metastatic
tumors in animals: MDA231 is MDAMB231, an estrogen receptor
negative breast carcinoma, inoculum 2 3 106 cells/CAM; HEp3 is an
epidermoid carcinoma, inoculum 1 3 106; HT1080 is a fibrosarcoma,
HT1080-1, inoculum 1 3 106/CAM, HT1080-2, inoculum 2 3 106
cells/CAM; PC3, an androgenreceptor negative prostate carcinoma,
inoculum 2 3 106 cells/CAM. CAMs, DNA from uninoculated CAMs;
Pos. Cont., a mixture of CAM and human DNA representing 800
Figure 6. Attachment of HEp3 Cells to Human HUVEC and Chickenhuman cells per CAM. The experiment was terminated at 54 hr.
Large Vessel EndotheliumIntravasation by all three cell types (except HEp3, which was re-
peated many times) was repeated at least three times, with similar HEp3 cells and their nonmalignant derivative (Ossowski and Reich,
1983a) were inoculated (1.0 3 104 cells per well), onto a 24-well trayresults.
(B) Human cells of lesser malignant potential or normal primary previously seeded with confluent HUVEC or chicken endothelium),
and, to mimic shearing stress in the circulation, the trays were ro-fibroblasts. HEp3 (1 3 106) used as a positive control; HEFare human
embryo fibroblasts, 7th passage in culture; MCF-7 is an estrogen tated at 60 rpm in a 378C incubator. The number of cells adhering
after 10 min was determined as described in Experimental Proce-receptor positive breast cancer cell line; LNCaP is an androgen-
dependent prostate cancer cell line; CAMs, DNA from uninoculated dures. The values shown are mean of four determinations; the bars
show standard deviation. The darker columns correspond to HEp3CAMs. All cells (except HEp3) were inoculated at 2 3 106 cells per
CAM. The experiment was repeated twice with similar results. cells; the lighter, to the nonmalignant HEp3 derivative.
Proteases in Cancer Intravasation and Alu-PCR
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Table 1. Production of uPA and Growth In Vivo
uPA Growth








uPA was measured by a chromogenic assay (see Experimental Pro-
cedures) in serum-free conditioned media collected over a 24 hr
period. Growth onCAM was determined 1 week after cell inoculation
and in two subsequent passages in vivo: 111 represent tumors
.200 mg that, when reinoculated on CAMs, continue to produce
large tumors; 1/2 represent very small nodules, ,40 mg. Tumor
cells can be discerned microscopically in mince of these nodules.
NT, not tested.
a Inoculum of 5 3 105 cells per CAM.
b Inoculum of 2 3 106 cells per CAM.
led us to conclude that the actual breaching of the blood
vessel wall had to be considered as the rate-limiting
step for intravasation.
Figure 7. Intravasation of Cells with Reduced Surface uPAR butThe Effect of Reduced Surface Proteolysis
Unaltered MMP Productionon Intravasation
(A) Intravasation. HEp3 cells (parental) or clones selected from HEp3
Since our own and other published evidence link cancer cells transfected with vector alone (LK 25) or with vector expressing
cell urokinase plasminogen activator (uPA) and metallo- uPAR-antisense RNA under b-actin promoter (AS33, AS48, AS24,
proteinases (MMPs) with degradation of extracellular and AS36), in which surface uPAR was reduced by more than 50%
(Yu et al., 1997), were maintained in vivo, and used to prepare singlematrix protein and invasion (see Mignatti and Rifkin,
cell suspension as previously described(Ossowski and Reich,1980).1993, for review), we tested whether these enzymes also
(Weights of tumors used to prepare cells for this experiment wereplayed a crucial role in invasion of blood vessels and
as follows: HEp3, 200 mg; LK 25, 170 mg; AS33, 160 mg; AS24, 90thus intravasation. uPA production was high in all cells
mg; AS36, 150 mg.) After 5 days of growth in culture, the cells were
that intravasated efficiently, but also in HEF cells (Table detached with EDTA, resuspended at 1 3 106 per 50 ml, and used
1) that did not intravasate at all, suggesting that uPA to inoculate duplicate CAMs. At 50 hr after inoculation, the CAMs
were processed for determination of intravasated cells as describedmay be necessary but not sufficient to accomplish this
in Experimental Procedures. The Alu-PCR±amplified bands weretask. To test its role more directly, intravasation of four
scanned by densitometer, and units obtained for each band areclones of HEp3 cells, in which surface urokinase plas-
shown. The experiment was repeated three times with essentiallyminogen activator receptor (uPAR) was reduced by up
similar results.
to 70% through transfection of a vector expressing anti- (B) MMP activity. Parallel cultures of cells tested for intravasation
sense RNA (Yu et al., 1997), was compared to that of were grown till confluence in 60 mm dishes, washed, and incubated
in serum-free medium for 24 hr. The media were collected, centri-parental HEp3 cells or a clone of HEp3 cells transfected
fuged to remove floating cells and debris, and 10 ml of each waswith vector alone (Figure 7A). Intravasation of cells with
analyzed for MMP activity by zymography (see Experimental Proce-low uPAR, and thus low surface uPA, was drastically
dures).reduced or completely blocked. This result shows that
surface uPA/uPAR are indispensable for intravasation.
To test whether there was a connection between intra- residual lysis zone of MMP-2 was present even when
1.6 mM was used (Figure 8B). We tested the effect ofvasation and MMP production, we examined the MMP
activities of all the cells tested in intravasation assays the inhibitor on intravasation of HEp3 cells in vivo by
mixing it with the inoculum and reapplying the inhibitorby gelatin zymography assay. This assay revealed a
varied profile of MMPs: some cells (MCF-7) with no de- to the site of inoculation after 24 hr. As shown in Figure
8C, 50 ml of 100 mM marimastat, which if distributedtectable MMPs, and others (HEp3 and MDAMB231) with
three lysis zones corresponding to MW of z92, 72, and evenly throughout the embryo and the extraembryonic
tissues should yield a final concentration of 100 nM,50 K (Figures 8A and 8B). The 92 K corresponds most
likely to MMP-9, and the 72 K to MMP-2. The 50 K lysis reduced the number of intravasated cells by more than
90%. In a separate experiment, we found that even azone was previously identified as MMP-1 (Ossowski,
1992). To test whether inhibition of MMPs will affect final concentration of 50 nM was sufficient to produce
.60% inhibition of intravasation (results not shown); aintravasation, we used a water-soluble MMP inhibitor,
marimastat. In an in vitro assay using a zymogram of higher inhibitor concentration (200 mM, Figure 8B) was
less effective (see Discussion). That the blocking of in-HEp3-conditioned medium as a source of MMPs, the
inhibitor at 80 nM concentration was sufficient to block travasation is the result of MMP inhibition, and not a
general toxic effect, was shown in an experiment inmost of the MMP-9 and all of the MMP-1 activity. A
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and the parental HEp3 cells, with similar levels of MMP-9
but with full complement of uPAR, intravasated very
efficiently (Figure 7A). This indicates that an effective
intravasation is accomplished only when both surface
uPA/uPAR and MMP-9 are present.
Discussion
Intravasation is one of the early steps of the multifaceted
process leading to metastasis. Metastatic cells translo-
cate between several compartments separated by vari-
ous physical barriers consisting of extracellular matrix,
basement membranes, and layers of tightly associated
cells. It is postulated that breaching of these barriers
must involve the activity of proteolytic enzymes such
as plasminogen activators, MMPs, and cathepsins (Mig-
natti and Rifkin, 1993, for review). While an intense scru-
tiny of extracellular matrix (ECM) invasion by cancer
cells provided unequivocal evidence for the involvement
of proteases, no consensus has been reached with re-
gard to their role in extravasation (Hearing et al., 1988;
Axelrod et al., 1989; Yu and Schultz, 1990; Kobayashi
et al., 1994; Hua and Muschel, 1996; Koop et al., 1996;
Chambers and Matrisian, 1997). Because an assay
allowing the study of the molecular requirements for
tumor cell intravasation per se (i.e., separate from other
metastatic steps) has not been available, only hints of
the requirement for protease in intravasation have beenFigure 8. The Role of MMPs in Intravasation
gleamed from experiments in which protease inhibitors(A) Secretion of MMPs by cells of different malignant potential. Cells
were effective in blocking spontaneous but not experi-used in intravasation experiment (Figure 4) were tested for MMP
mental metastasis, and from other indirect evidenceactivity as described in Figure 7B. (Left and right panels show indi-
vidual experiments.) (Ossowski, 1988b; Kobayashi et al., 1994). The combina-
(B) In vitro inhibition of MMP activity by marimastat (BB-2516). Se- tion of our chick embryo/human cancer cell metastasis
rum-free conditioned medium of HEp3 cells (10 ml) was loaded into model (Ossowski and Reich, 1980, 1983b) with a PCR-
each of 5 wells, the proteins separated by PAGE, the gel sliced
based method for detection of human cancer cells haslongitudinally to include one sample per slice, and incubated as
now allowed us to develop the first semiquantitativedescribed in Experimental Procedures, except that marimastat at
assay for the analysis of human tumor cell intravasationthe indicated concentrations (0±1.6 mM) was added to the incubation
buffer and the gels were incubated only for 22 hr. (MMP-2 activity in a xenogeneic host. Chief features of the assay are its
was not completely inhibited even at the highest concentration sensitivity (as few as 50 intravasated cancer cells per
tested.) 1 3 108 host cells can be detected), its dependence on
(C) Inhibition of intravasation by marimastat. HEp3 cells (1 3 106)
tumor cell inoculum, its time dependence (consistentwere suspended in 50 ml PBS without or with 0.1 or 0.2 mM marima-
with rate-limiting stepsfor intravasation), its applicabilitystat, and inoculated in triplicate on upper CAM inside a Teflon ring
to any established cancer cell line or tumor explants,(see Experimental Procedures). (We estimate that, after diffusion in
the embryo whose volume is z50 ml, the final in vivo concentration and its potential extrapolation to other xenogeneic
of this water-soluble compound is 100 and 200 nM, respectively.) hosts, such as nude or SCID mice.
At 24 hr after inoculation, the embryo received a second dose of Why is the chick embryo/human cancer cell model
marimastat, and at 50 hr postinoculation, the human DNA content
amenable to direct testing of intravasation? First, asof the lower CAMs (intravasated cells) was determined.
we (and others) have shown (Armstrong et al., 1982;
Ossowski, 1988a), it is possible to modify the site of
inoculation on the CAM such that even noninvasive cellswhich 50 mM marimastat was added to cultures of HEp3
cells and reapplied 24 hr later. After 48 hr of treatment, can infiltrate its connective tissue. This modification is
incidental to creation of an artificial air sac for cancerthere was neither microscopically visible toxicity nor
reduced cell proliferation, as compared to untreated cell inoculation. During this process, the chorionic epi-
thelium and underlying basement membrane are dam-controls (results not shown). Individually, this result can-
not identify the specific MMP responsible for intravasa- aged, exposing loose connective tissue richly supplied
with capillary blood vessels. In such wounded CAMs,tion. However, since of the seven cell lines tested only
the four that expressed MMP-9 activity were capable of cancer cells have seemingly unhindered access to capil-
laries, such that only their ability to breach the capillaryintravasation, it is most likely that MMP-9 is the required
enzyme. It must be noted, however, that in spite of vessel wall determines whether they will intravasate.
Another obstacle to the measurement of cancer cellproducing high levels of MMP-9 (Figure 7B), the low-
expressing uPAR-clones (AS 24 and 33) with low surface intravasation has been the inefficiency of this process,
which precludes direct visualization or quantitation ofuPA intravasated very poorly (Figure 7A). Vector control
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cells and necessitates highly sensitive and specific inoculated CAMs, we expect that they would not show
substantial differences. First, during the first 2 days ofmethods for theirdetection. The useof Alu sequences as
template for PCR amplification provided the necessary incubation, there is no clear delineation of the tumor,
as most of it is composed of the inoculated cells. Inlevel of specificity and sensitivity. This approach has
been attempted recently to detect human lymphoma addition, while most blood vessels in adult organisms
are in a quiescent state until pathology such as rapidcells in SCID mice (Zubair et al., 1996), but met with
limited success. In our hands, this method, which de- tumor growth induces neovascularization, vessels in the
developing CAM are in a continuous state of growth,tected as few as 50 cells in the entire lower CAM of a
chick embryo, was at least 100-fold more sensitive than thus mimicking to a certain degree tumor vasculature.
Also, we found that HEp3 cells, which express a veryPCR amplification of the globin gene (Noguchi-Takino
et al., 1996, and results not shown). These authors used high level of VEGF, and HT1080, in which VEGF expres-
sion is barely detectable (results not shown), are equallyb-globin PCR amplification and Southern blotting to de-
tect tumor cells in chick embryo liver 1 week after intra- efficient in intravasation.
Like the placental circulation in mammals, the CAMvenous injection of 1 3 106 cells. As shown in Figure 5,
our method detects 1 3 105 cells (and even 1 3 104 circulation provides oxygenated blood that, through the
chorioallantoic vein, enters the portal circulation of thecells, results not shown) 4 hr after intravenous injection.
As seen in Figure 2B, there was a progressive increase embryo. Thus, cells intravasating from an inoculation
site on the CAM encounter the capillary beds of thein PCR-band intensity with increasing cancer cell num-
bers. However, the slope of the curve was z1 in the CAM and the liver. In several experiments, genomic DNA
was extracted from the lower CAMs and the livers ofrange of 50±800 cancer cells, and ,1 for larger cell
numbers. This indicates that in cases whencomparisons embryos inoculated with HEp3 cells (the largest of all
cells used). We found (results not shown) that, on a perare made between poorly intravasating cells (i.e., low
uPAR or low MMP activity) and cells that intravasate milligram of tissue basis, CAMs, which have a higher
blood vessel density than livers, had a slightly higherefficiently, the level of intravasation by the latter may
be underestimated by this method. number of arrested cells. These results suggest that,
unlike intravenously injected cells, which usually arrestAlthough PCR can amplify genomic DNA irrespective
of its origin (live cells or phagocytized cell debris), for in the first capillary bed, cells that enter the circulation
by intravasation are capable of bypassing such a barrier.the following reasons we concluded that in our experi-
ments the source of DNA is mostly live cancer cells. Since all the other cell types tested have smaller than
HEp3 diameters, there is no reason to believe that ab-First, macrophages begin to mature on day 17 of chick
embryo development, several days after termination of sence of detection in the lower CAM is due tocell entrap-
ment at the site of intravasation.the experiment. Moreover, PCR signal obtained on day
5 of inoculation was of much greater intensity than the Another aspect to be considered when comparing
intravasation of different cell types is their ability to ar-signal on day 2 (Figures 2F and 4B), and this only hap-
pened in embryos inoculated with cells capable of intra- rest, and thus survive, in the blood vessels. Inability to
attach to the endothelium may lead to repeated recircu-vasation. In addition, we compared PCR-band intensity
produced by samples of lower CAMs at 50 hrafter inocu- lation and death due to shearing stress. We excluded
this possibility by showing that parental HEp3 cells withlation with HEp3 cells to samples of the same CAMs
reimplanted and grown in vivo for 1 week. We observed the highest observed intravasation potential, and their
nonmalignant derivative (Ossowski and Reich, 1983a),a strong increase in DNA Alu-band intensity, indicating
that the inoculum contained live cancer cells (results incapable of intravasation (results not shown), adhered
to chicken endothelium with the same affinity. Moreover,not shown).
We concluded that the presence of human DNA in the similar numbers of cells were recovered from the lower
CAMs after intravenous injection of different cell types,lower CAMs of embryos inoculated onthe ªupper CAMsº
indicates that cancer cells must be able to breach intact including normal fibroblasts, into an upper CAM blood
vessel. This indicates that once the blood vessel wallwalls of blood vessels, disseminate, and arrest in small
blood vessels of the chick embryo tissues, including the is breached (by injecting cells into the circulation), the
constraints that prevented cancer cells from dissemina-lower CAM. Is this conclusion supported by evidence,
or are other interpretations possible? Are the blood ves- tion from the primary site are no longer operational. We
have also showed that proliferation rate did not affectsels in the CAMs damaged due to wounding, or not
completely formed, providing direct access to the inocu- to a large degree the number of cells recovered from
the lower CAM.lated cells? We showed that cancer cells were not de-
tected in the lower CAM for as long as 32 hrafter inocula- The sum of these results indicates that intrinsic prop-
erties of cancer cells, other than their size, ability totion. In CAMs removed 5 min after inoculation, a time
at which blood vessel damage, if present, should be adhere to endothelium, or rate of in vivo proliferation
are responsible for the observed differences in intrava-most pronounced, no cancer cells were found in the
lower CAM. Likewise, published reports show that al- sation.
What might these intrinsic properties be? The needready on day 6 the embryonic blood vessels are fully
formed and poorly permeable to proteins larger than 40 for tumor cell translocation across a biological barrier
and previous, indirect evidence (Ossowski, 1988b) sug-kDa (Rizzo et al., 1993), indicating that translocation of
a cancer cell from the outside to the inside of a blood gested the possibility of protease involvement. We have
now used the intravasation assay to identify key prote-vessel is an active process. Although we did not directly
compare the vasculature in normal versus tumor cell± ases required for intravasation. As shown in Figures 7
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and 8 and Table 1, our data indicate that only cells with cascade. Although physiological activators of pro-
MMP-9 have not been identified, recent evidence (Maz-a high level of uPAR/uPA that also produced MMPs,
specifically MMP-9, were capable of efficient intravasa- zieri et al., 1997) suggests that both pro-MMP-2 and
MMP-9 can be activated by PA/plasmin. More impor-tion. Cells with reduced surface uPAR (and indirectly
uPA) that we characterized previously (Yu et al., 1997) tantly to our findings, these authors have shown that
binding of uPA to its receptor increases pro-MMP acti-intravasated very poorly. To test the role of MMPs,
whose role in facilitating the breakdown of physical bar- vation, and that in absence of cells, plasmin not only
fails to activate pro-MMPs, but rapidly degrades them.riers as prerequisite for metastasis has recently been
challenged (Chambers and Matrisian, 1997), we used Should this pathway of MMP activation prove to be
prevalent, it would explain why interfering with only onemarimastat, an inhibitor of MMPs. This water-soluble
compound, like the better-described, poorly soluble element, uPAR or MMP, has such powerful biologic
effect.batimastat (Davies et al., 1993; Eccles et al., 1996), con-
tains a hydroxamic group that interacts with the catalyti-
Experimental Procedurescally active Zn in MMPs. Both compounds inhibit
MMP-1, MMP-2, MMP-3, MMP-7, and MMP-9 with IC50
Reagentsof 1±20 nM (Davies et al., 1993; Sundareshan et al.,
Tissue culture media, glutamine, and antibiotics were purchased
1997). We used 50 ml of 50±200 mM inhibitor (Figure 8C, from GIBCO Laboratories (Grand Island, NY); trypsin from ICN Phar-
and results not shown), which, when equilibrated in the maceuticals Inc. (Costa Mesa, CA); fetal bovine serum from JRH
chick embryo tissues (total weight of z50 g) should Biosciences (Lenexa, KS); gelatin from porcine skin, collagenase
type 1A, BSA, fibronectin, and heparin from Sigma Chemicals (St.produce, at least temporarily, final concentrations of
Louis, MO); acidic fibroblast growth factor from Collaborative Re-50±200 nM. This concentration is above the published
search (Bedford, MA); chromogenic substrate for plasminogen,IC50 and compatible with our in vitro results (Figure 8B). Spectrozyme PL from American Diagnostica (Greenwich, CT); hu-
We found that 100 mM marimastat (final 100 nM) pro- man serum type A (heat inactivated) was prepared from platelet-
duced the most pronounced inhibition of intravasation, poor plasma and human plasminogen was purified from fresh frozen
while 200 and 50 mM were less effective. It is possible human plasma, DNA Isolation Systems from Oncogene Research
products (Cambridge, MA) for initial experiments and Puregene fromthat at the highest concentration used marimastat inhib-
Gentra (Minneapolis, MN); Amplitaq Gold Taq Polymerase fromits chick embryo MMPs, interfering with the turnover of
Perkin Elmer (Branchburg, NJ); dNTPs from New England Biolabsthe basement membrane of the vessel wall, making it
(Boston, MA); 32P-adCTP and 125I-UdR from New England Nuclear
more permissive to invasion. Since marimastat inhibits (Boston, MA); COFAL-negative embryonated eggs from Specific
all three of the MMPs (MMP-1, -2, and -9) produced by Pathogen-Free Avian Supply (SPAFAS) (Norwich, CT); PCR primers
the cancer cell lines used in our study, it alone can- and probes were from Genelink Inc. (Thornwood, NY). Collagenase
inhibitor BB-2516 (marimastat) was a generous gift from British Bio-not identify the enzyme crucial for intravasation. How-
tech. Pharmaceuticals Ltd. The following human cells or cell linesever, we found that only cells such as HEp3, HT1080,
were used: epidermoid carcinoma (HEp3); estrogen receptor nega-MDAMB231, and PC3, which produce high levels of both
tive (MDAMB231) and positive (MCF-7) breast cancer cell lines;
uPA and MMP-9, were capable of intravasation. Since androgen receptor negative (PC3) and positive (LNCaP) prostate
we only used zymography to examine MMPs, we cannot cancer cell lines, fibrosarcoma (HT1080), and human embryo fibro-
draw final conclusions on the state of their activation. blasts (HEF), a gift from Dr. E. L. Wilson, Cape Town, South Africa.
HEp3, HT1080, and HEF were cultured in Dulbecco's modified MEMHowever, since inhibition of MMP activity has such a
with 10% heat-inactivated FBS, (HI-FBS); MDAMB231, MCF-7, PC3,potent effect, they most likely have to be present in
and LNCaP were cultured in RPMI with HI-FBS; for MDAMB231 andactive form, at least in vivo. In fact, medium collected
MCF-7 cells, the medium was supplemented with 5 mg/ml of insulin.
from HEp3 tumor fragments over a period of 6 hr shows HEp3 transfected with LK444 (vector control, designated clone LK
additional bands of lysis corresponding to active forms 25) or HEp3 cells transfected with LK444 vector expressing anti-
of MMP-9 and MMP-2 (results not shown). This observa- sense uPAR-RNA (AS-24, -33, -36, and -48) and in which surface
uPAR was reduced by up to 70% were described previously (Yu ettion fits well with published evidence in squamous cell
al., 1997).carcinomas of the head and neck (the origin of HEp3
cells), indicating interactions between cancer cells and
In Vivo Experiments
stroma leading to induction of proteolytic enzyme activ- For intravasation, invasion, and tumor passage experiments, chick
ity (Matsumoto et al., 1989; Lengyel et al., 1995). A direct embryos were obtained at 8 days of gestation and were maintained
examination of gene expression incancer cells following at 378C in a humidified, rotating incubator from Lyon Electronic
Company, Inc. (Chula Vista, CA). HEp3 cells, AS-clones, and LK 25intravenous injection into CAM vessels showed a suc-
vector control clone were maintained in vivo by serial weekly pas-cessive turning on of transcription, with uPA increasing
sage of tumor fragments.at 9 hr after injection, possibly at a time when extravasa-
tion begins (Shioda et al., 1997).
Intravasation
Two models can be envisioned to explain the role for For intravasation experiments, the HEp3 tumors were dissociated
these two proteases; it is possible that different compo- with collagenase as described (Ossowski and Reich, 1980), plated
nents (e.g., laminin versus collagen type IV, etc.) of the at high density (3 3 106 cells per 100 mm dish), and passaged
once 24 to 48 hr prior to the experiment. Cultured cells used forbasement membrane have to be degraded sequentially
intravasation were also passaged 24 to 48 hr prior to experiment.by uPA/plasmin and MMP-9. Degradation of one com-
Cells were detached from the culture dish with 2 mM EDTA in PBS,ponent of the matrix may facilitate access to, or degra-
counted, resuspended in 50 ml of PBS with Ca21 and Mg21, and
dation of, additional components, breaking the physical inoculated (usually at 106 cells, unless indicated otherwise) onto a
integrity of basement membrane and allowing cancer CAM of a 9-day-old chick embryo, in which an artificial air sac was
cell translocation. It is as likely, however, that uPA/plas- created (designated ªupper CAMº; see Figure 1). After 50 hr of
incubation (unless specified otherwise), the lower half of the CAMmin and pro-MMP-9 represent components of the same
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(designated ªlower CAMº; Figure 1) was removed, placed in a sterile Protease Assays
uPA Assay14 ml polypropylene tube, the tissue was snap-frozen in liquid nitro-
gen, and stored frozen at 2808C. For the time dependence experi- Cells were plated in 6-well trays and grown to near confluence, the
medium was removed, and the cells were washed and incubatedment, the cells were inoculated inside 8 mm inner diameter sterile
teflon rings (removed from 1.8 ml freezing vials, Nunc, Denmark). with 2 ml of serum-free medium for 24 hr. The medium was collected,
centrifuged, and frozen until assayed. The cells were lysed in 300This prevented leaking and spreading of cells when the lower CAMs
had to be removed early (5 min, 6 hr) after inoculation. To test for ml of 0.1 M Tris (pH 8.1) and 0.1% Triton X-100. The uPA (10 ml of
conditioned medium and 10 mg of cell protein) was assayed asinhibition by marimastat (BB-2516), HEp3 cells were prepared as
above, but one group was resuspended in PBS with Ca21 and Mg21, previously described (Mira y Lopez and Ossowski, 1987), using plas-
minogen and chromogenic plasminogen substrate.while two others were resuspended in 100 or 200 mM inhibitor in
PBS with Ca21 and Mg21. The cells were inoculated inside teflon Gelatin Gel Zymography
Ten microliter aliquots of conditioned media were electrophoresedrings and the inhibitor reapplied 24 hr later.
at 48C on 8% PAGE containing 0.1% gelatin, the gel washed in 2.5%
Triton X-100 for 30 min, rinsed in water, and incubated for 40 hr atIntravenous Injection
378C in buffer containing 50 mM Tris (pH 7.7), 5 mM CaCl2, andCells prepared as above (using EDTA in PBS for detachment) were
0.02% NaN3. To test for inhibition of MMPs by BB2516, HEp3 cell±resuspended at 1±2 3 105 per 50 ml of PBS containing Ca21 and Mg21
conditioned medium was electrophoresed in quadruplicate. The geland using 28-gauge hypodermic needles injected intravenously into
was cut into four fragments, each containing one sample (lane) and10.5-day-old chick embryos, prepared by opening a small ªwindowº
incubated separately as above, except that marimastat was addedin the eggshell, but without dropping the CAM, such that the CAM
in increasing concentration to the incubation buffer. All gels werevessels were easily accessible for injection. At 4 hr, the lower CAM
stained with Coomassie blue, destained, and dried between dialysiswas removed, snap-frozen, and used to extract genomic DNA.
sheets.
Preparation of Chicken and Human Endothelium
Acknowledgmentsand Adhesion Studies
Human umbilical vein endothelium (HUVEC) was prepared as de-
We thank British Biotech Pharmaceuticals Ltd., Oxford, UK, for thescribed (Jaffe, 1984) and grown ondishes precoated with fibronectin
generous gift of marimastat (BB-2516); Dr. Rafael Mira y Lopez for(50 mg/ml) in medium M199 with 20% human serum, 50 mg/ml hepa-
critical reading of the manuscript; Ms. Uma Rao for help with therin, and 100 ng/ml of bFGF. Chick endothelium was prepared from
graphics; and Dr. Samuel Waxman for continuous encouragementblood vessels of 15-day-old chick embryos, using a miniaturized
and support. This work was supported by U.S. Public Health ServiceHUVEC preparation method, and grown under the same conditions
Research Grant CA-40758 (L. O.) and The Samuel Waxman Canceras HUVEC except that the medium was supplemented with 30%
Research Foundation.human serum and 1% egg yolk. For experiments, the endothelial
cells were plated at 1.5 3 104 cells per well in a 24-well tray and
incubated in full medium for 3±4 days, washed, and incubated for Received June 2, 1998; revised July 1, 1998.
24 hr in growth; yolk was not added to chick endothelium. Tumor
cells labeled for 20 hr with 125I-UdR were washed extensively, de-
Referencestached, resuspended at 1 3 104 cells/ml and 0.5 ml of Dulbecco's
medium with 10 mM HEPES and 1 mg/ml BSA, and inoculated into
Armstrong, P.B., Quigley, J.P., and Sidebottom, E. (1982). Transepi-wells with endothelium. The trays were rotated at 60 rpm at 378C
thelial invasion and intramesenchymal infiltration of the chick em-for 10 min, the floating cells aspirated, the monolayers washed three
bryo chorioallantois by tumor cell lines. Cancer Res. 42, 1826±1837.times, and the remaining cells solubilized in 1 N NaOH and counted
in a g-counter. Adhesion of tumor cell to endothelium is expressed Axelrod, J.H., Reich, R., and Miskin, R. (1989). Expression of human
as percent of radioactivity (cpm) in the inoculum. recombinant plasminogen activators enhances invasion and experi-
mental metastasis of H-ras-transformed NIH 3T3 cells. Mol. Cell
Biol. 9, 2133±2141.Growth of Cancer Cells on CAM
After an artificial air sac was formed, cancer cells growing in tissue Chambers, A.F., and Matrisian, L.M. (1997). Changing views of the
role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst.culture were inoculated on CAMs at 5 3 105 or 2 3 106 cells per
CAM, on three to four CAMs each. After 1 week of incubation, 89, 1260±1270.
nodules or tumors formed at the site of inoculation were excised, Davies, B., Brown, P.D., East, N., Crimmin, M.J., and Balkwill, F.R.
weighed, minced, and inspected microscopically for the presence (1993). A synthetic matrix metalloproteinase inhibitor decreases tu-
of cancer cells. The mince of small nodules was reinoculated on mor burden and prolongs survival of mice bearing human ovarian
fresh CAMs for 2 consecutive weeks. carcinoma xenografts. Cancer Res. 53, 2087±2091.
Eccles, S.A., Box, G.M., Court, W.J., Bone, E.A., Thomas, W., and
DNA Extraction and Human Alu Sequence PCR Amplification Brown, P.D. (1996). Control of lymphatic and hematogenous meta-
The frozen tissue was crushed in lysis buffer with sterile 5 ml pi- stasis of a rat mammary carcinoma by the matrix metalloproteinase
pettes. Genomic DNA was isolated from lower CAMs using DNA inhibitor batimastat (BB-94). Cancer Res. 56 2815±2822.
Isolation Kit (Gentra Systems) as per manufacturer's specifications. Foltz, C.M., Rusoo, R.G., Siegal, G.P., Terranova, V.P., and Liotta,
Specific primers for human Alu sequences were Alu- sense, 59 ACG L.A. (1982). Interaction of tumor cells with whole basement mem-
CCT GTA ATC CCA GCA CTT 39, and Alu-antisense, 59 TCG CCC brane in the presence or absence of endothelium. In Interaction of
AGG CTG GAG TGC A 39, which produced a band of 224 bp. The Platelets and Tumor Cells, G.A. Jamieson, ed. (New York: Alan R.
primers were positioned in the most conserved areas of the Alu Liss, Inc.), pp. 353±371.
sequence (Kariya et al., 1987) (first monomer, nt 21-40, and in the
Hearing, V.J., Law, L.W., Corti, A., Apella, E., and Blasi, F. (1988).second monomer, nt 263-245). The PCR was performed under the
Modulation of metastatic potential by cell surface urokinase of mu-following conditions: 958C for 10 min, 958C for 30 s, 588C for 45 s,
rine melanoma cells. Cancer Res. 48, 1270±1278.728C for 45 s, and 728C for 10 min. The reaction mixture contained
Hua, J., and Muschel, R. (1996). Inhibition of matrix metallopro-1 mg of genomic DNA as template, 13 PCR buffer, 1.5 mM MgCl2,
teinase 9 expression by a ribozyme blocks metastasis in rat sarcoma50 mm dNTPs, 1.0 mM each of Alu-sense and -antisense primers,
model system. Cancer Res. 56, 5279±5284.1±2 units of Amplitaq Gold, and 0.1 mCi fresh 32P-a-dCTP. The PCR
products were electrophoresed on a 7% polyacrylamide gel at 100 Jaffe, E.A. (1984). Culture and identification of large vessel endothe-
lial cells. In Biology of Endothelial Cells, E.A. Jaffe, ed. (Boston:V for 1 hr, dried, and exposed to film at 2808C. The bands were
quantitated by densitometric scanning using GelScan XL (Phar- Martinus Nijhoff Publishers, Kluwer Academic Publishers Group),
pp. 1±13.macia, Upsala, Sweden).
Cell
362
Kariya, Y., Kato, K., Hayashizaki, Y., Himeno, S., Tarui, S., and Matsu- Zubair, A.C., Ali, S.A., Rees, R.C., Goepe, J.R., and Goyns, M.H.
bura, K. (1987). Revision of concensus sequence of human Alu re- (1996). Investigation of the effect of BB-94 (batimastat)on the coloni-
peatsÐa review. Gene 53, 1±10. zation potential of human lymphoma cells in SCID mice. Cancer
Lett. 107, 91±95.Kobayashi, H., Gotoh, J., Shinohara, H., Moniwa, N., and Terao,
T. (1994). Inhibition of the metastasis of Lewis lung carcinoma by
antibody against urokinase-type plasminogen activator in the exper-
imental and spontaneous metastasis model. Thromb. Haemost. 71,
474±480.
Koop, S., Schmidt, E.E., MacDonald, I.C., Morris, V.L., Khokha, R.,
Grattan, M., Leone, J., Chambers, A.F., and Groom, A.C. (1996).
Independence of metastatic ability and extravasation: metastatic
ras-transformed and control fibroblasts extravasate equally well.
Proc. Natl. Acad. Sci. USA 93, 11080±11084.
Lengyel, E., Gum, R., Juarez, J., Clayman, G., Seiki, M., Sato, H.,
and Boyd, D. (1995). Induction of M(r) 92,000 type IV collagenase
expression in a squamous cell carcinoma cell line by fibroblasts.
Cancer Res. 55, 963±967.
Matsumoto, K., Horikashi, M., Rikimaru, K., and Enomoto, S. (1989).
A study of an in vitro model for invasion of oral squamous cell
carcinoma. J. Oral Pathol. Med. 18, 498±501.
Mazzieri, R., Masiero, L., Zanetta, L., Monea, S., Onisto, M., Garbisa,
S., and Mignatti, P. (1997). Control of type IV collagenase activity
by components of the urokinase-plasmin system: a regulatory
mechanism with cell-bound reactants. EMBO J. 16, 2319±2332.
Mignatti, P., and Rifkin, D.B. (1993). Biology and biochemistry of
proteinases in tumor invasion. Physiol. Rev. 73, 161±194.
Mira y Lopez, R., and Ossowski, L. (1987). Hormonal modulation of
plasminogen activator: an approach to prediction of human breast
tumor responsiveness. Cancer Res. 47, 3558±3564.
Noguchi-Takino, M., Endo, Y., Yonemura, Y., and Sasaki, T. (1996).
Relationship between expression of plasminogen activator system
and metastatic ability in human cancers. Int. J. Oncol. 8, 97±105.
Ossowski, L. (1988a). In vivo invasion of modified chorioallantoic
membrane by tumor cells: the role of surface-bound urokinase. J.
Cell Biol. 107, 2437±2445.
Ossowski, L. (1988b). Plasminogen activator dependent pathways
in the dissemination of human tumor cells in the chick embryo. Cell
52, 321±328.
Ossowski, L. (1992). Invasion for connective tissue by human carci-
noma cell lines: requirement for urokinase, urokinase receptor, and
interstitial collagenase. Cancer Res. 52, 6754±6760.
Ossowski, L., and Reich, E. (1980). Experimental model for quantita-
tive study of metastasis. Cancer Res. 40, 2300±2309.
Ossowski, L., and Reich, E. (1983a). Changes in malignant pheno-
type of human carcinoma conditioned by growth environment. Cell
33, 323±333.
Ossowski, L., and Reich, E. (1983b). Antibodies to plasminogen
activator inhibit human tumor metastasis. Cell 35, 611±619.
Poste, G., Doll, J., Hart, I.R., and Fidler, I.J. (1980). In vitro selection
of murine B16 melanoma variants with enhanced tissue-invasive
properties. Cancer Res. 40, 1636±1644.
Rizzo, V., Steifeld, R., Kyriakides, C., and DeFouw, D.O. (1993). The
microvasculature unit of the 6-day chick chorioallantoic membrane:
a fluorescent confocal microscopyand ultrastructural morphometric
analysis of endothelial permselectivity. Microvasc. Res. 46, 320±332.
Shioda, T., Munn, L.L., Fenner, M.H., Jain, R.K., and Isselbacher,
K.J. (1997). Early events of metastasis in the microcirculation involve
changes in gene expression of cancer cells. Tracking mRNA levels
of metastasizing cancer cells in the chick embryo chorioallantoic
membrane. Am. J. Pathol. 150, 2099±2112.
Sundareshan, P., Kostler, J.J., Nagle, R.B., and Bowden, G.T. (1997).
Coordinated expression of matrilysin during TPA-inducedapoptosis
of LNCaP cells: two parallel processes affected by TPA. Cancer
Lett. 113, 17±24.
Yu, H., and Schultz, R.M. (1990). Relationship between secreted
urokinase plasminogen activator activity and metastatic potential
in murine B 16 cells transfected with human urokinase sense and
antisense genes. Cancer Res. 50, 7623±7633.
Yu, W., Kim, J., and Ossowski, L. (1997). Reduction in surface uroki-
nase receptor forces malignant cells into protracted state of dor-
mancy. J. Cell Biol. 137, 767±777.
